Try our mobile app

Switch to company model in classical logic    *

General information

Country: ISRAEL

Sector: Drug Manufacturers — Specialty and Generic

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers` diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, with a planned Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), a SK2 selective inhibitor targeting various indications with a Phase 2/3 program for COVID-19 and Phase 2 studies for prostate cancer and cholangiocarcinoma ongoing; RHB-104, which is in Phase 3 studies for Crohn`s disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and in Phase 2 studies for irritable bowel syndrome with diarrhea; RHB-107, a Phase 2-stage serine protease inhibitor for cancer and inflammatory gastrointestinal diseases, and is also being evaluated for COVID-19; and RHB-106, an encapsulated bowel preparation. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.
Website: redhillbio.com



Growth: Bad revenue growth rate -88.9%, there is slowdown compared to average historical growth rates 29.7%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +140.5%. On average the margin is improving steadily. Gross margin is high, +55.1%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 0% of quarters (showing a gain of -$0.18 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 1 109.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 255.0% higher than minimum and 91.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 7.9x by EV / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: RDHL
Share price, USD:  (0.0%)1.03
year average price 2.3122  


year start price 6.2600 2025-01-08

max close price 6.5900 2025-01-22

min close price 1.0150 2025-11-24

current price 1.0300 2026-01-07
Common stocks: 6 478 055

Dividend Yield:  0.0%
FCF Yield LTM: 1 109.0%
EV / LTM EBITDA: 0.0x
EV / EBITDA annualized: 0.1x
EV / Sales: 0.0x
Margin (EBITDA LTM / Revenue): 140.5%
Fundamental value created in LTM:
Market Cap ($m): 7
Net Debt ($m): -5
EV (Enterprise Value): 2
Price to Book: -1.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-04-28prnewswire.com

RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107

2025-04-10prnewswire.com

RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights

2024-12-02prnewswire.com

RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

2024-10-22prnewswire.com

RedHill Announces Collaboration with a Leading U.S. Academic Medical Center to Develop Opaganib as a Countermeasure Against Phosgene Inhalation Injury

2024-09-03prnewswire.com

New Peer-Reviewed Publication of Opaganib Phase 2/3 Data Shows 62% Reduction in COVID-19 Mortality

2024-08-16prnewswire.com

RedHill Biopharma Announces Plan to Implement ADS Ratio Change

2024-08-01investorplace.com

Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?

2024-07-22prnewswire.com

RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien

2023-12-20Market Watch

RedHill Biopharma shares jump as Ebola treatment shows promise

2023-11-30InvestorPlace

Why Is Redhill Biopharma (RDHL) Stock Down 27% Today?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q2 2025 q1 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2025-06-30 2025-03-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RDHL RDHL RDHL RDHL RDHL RDHL RDHL
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-05 2025-04-10 2023-08-17 2023-08-17 2022-12-31 2022-09-30 2022-06-30
acceptedDate 2025-09-05 07:06:42 2025-04-10 07:51:10 2023-08-17 07:07:20 2023-08-17 07:07:20 2022-12-31 00:00:00 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2025 2025 2023 2023 2022 2022 2022
period Q2 Q1 Q2 Q1 Q4 Q3 Q2
revenue 2M 2M 2M 4M 13M 18M 18M
costOfRevenue 803 500 803 500 806 000 2M 9M 9M 9M
grossProfit 1M 1M 990 000 2M 4M 8M 9M
grossProfitRatio 0.606 0.606 0.551 0.552 0.328 0.462 0.51
researchAndDevelopmentExpenses 482 000 482 000 1M 1M 1M 2M 1M
generalAndAdministrativeExpenses 2M 2M 4M 6M 33M 7M 8M
sellingAndMarketingExpenses 1M 1M 5M 5M -20M 7M 9M
sellingGeneralAndAdministrativeExpenses 3M 3M 8M 11M 13M 14M 17M
otherExpenses 0 0 -4M -39M 0 0 0
operatingExpenses 3M 3M 5M -27M 14M 15M 19M
costAndExpenses 4M 4M 6M -25M 23M 25M 28M
interestIncome 0 0 7M 22M -5M 3M 2M
interestExpense 512 000 512 000 2M 421 000 1M 32M 4M
depreciationAndAmortization 84 000 84 000 1M 455 694 10M 5M 4M
ebitda -2M -2M 3M 51M -294 000 -2M -6M
ebitdaratio -1.032 -1.032 1.496 30.883 -0.023 -0.104 -0.304
operatingIncome -2M -2M -4M 51M -10M -7M -9M
operatingIncomeRatio -1.073 -1.073 -2.454 14.077 -0.777 -0.405 -0.499
totalOtherIncomeExpensesNet 122 500 122 500 5M -421 000 6M -29M -3M
incomeBeforeTax -2M -2M 761 000 50M -4M -36M -12M
incomeBeforeTaxRatio -1.013 -1.013 0.424 13.96 -0.291 -2.034 -0.638
incomeTaxExpense 0 0 0 421 000 -6M 29M 3M
netIncome -2M -2M 761 000 50M 2M -64M -14M
netIncomeRatio -1.013 -1.013 0.424 13.96 0.195 -3.663 -0.777
eps -1 -1 4.83 20.44 1.61 -40.29 -0.25
epsdiluted -1 -1 4.83 20.44 1.61 -40.29 -0.25
weightedAverageShsOut 2M 2M 157 678 2M 2M 2M 57M
weightedAverageShsOutDil 2M 2M 157 678 2M 2M 2M 57M
link Link Link Link Link
finalLink Link Link Link Link

Balance Sheet Statement

Property 2025 q2 2025 q1 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2025-06-30 2025-03-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RDHL RDHL RDHL RDHL RDHL RDHL RDHL
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-05 2025-04-10 2023-08-17 2023-08-17 2022-12-31 2022-09-30 2022-06-30
acceptedDate 2025-09-05 07:06:42 2025-04-10 07:51:10 2023-08-17 07:07:20 2023-08-17 07:07:20 2022-12-31 00:00:00 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2025 2025 2023 2023 2022 2022 2022
period Q2 Q1 Q2 Q1 Q4 Q3 Q2
cashAndCashEquivalents 3M 3M 7M 18M 20M 15M 27M
shortTermInvestments 0 0 18 000 15 000 15 000 15 000 15 000
cashAndShortTermInvestments 3M 3M 7M 18M 20M 15M 27M
netReceivables 6M 5M 6M 12M 35M 39M 37M
inventory 3M 3M 5M 6M 11M 13M 12M
otherCurrentAssets 160 000 1M 9M 11M 20M 16M 16M
totalCurrentAssets 13M 13M 27M 47M 86M 83M 91M
propertyPlantEquipmentNet 289 000 289 000 2M 7M 7M 7M 8M
goodwill 0 0 0 -60M 0 0 0
intangibleAssets 6M 6M 6M 66M 66M 0 0
goodwillAndIntangibleAssets 6M 6M 6M 6M 66M 67M 69M
longTermInvestments 0 0 0 146 001 0 0 0
taxAssets 0 0 0 -146 001 0 0 0
otherNonCurrentAssets 0 0 143 917 146 000 150 000 148 000 150 000
totalNonCurrentAssets 6M 6M 8M 12M 73M 74M 77M
otherAssets 0 0 83 0 0 0 0
totalAssets 18M 18M 35M 59M 159M 157M 168M
accountPayables 835 000 835 000 3M 4M 4M 5M 4M
shortTermDebt 214 000 214 000 1M 979 000 116M 115M 87M
taxPayables 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0
otherCurrentLiabilities 21M 21M 24M 43M 77M 74M 75M
totalCurrentLiabilities 22M 22M 28M 48M 197M 194M 166M
longTermDebt 0 0 994 000 6M 6M 6M 7M
deferredRevenueNonCurrent 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0
otherNonCurrentLiabilities 500 000 500 000 2M 2M 3M -110M -78M
totalNonCurrentLiabilities 500 000 500 000 3M 8M 10M 10M 13M
otherLiabilities 0 0 35 0 0 0 0
capitalLeaseObligations 214 000 214 000 2M 7M 7M 7M 8M
totalLiabilities 23M 23M 32M 57M 207M 203M 180M
preferredStock 0 0 0 0 0 0 0
commonStock 63M 63M 5M 3M 3M 2M 2M
retainedEarnings -418M -418M -382M -383M -434M -431M -397M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 0 0
othertotalStockholdersEquity 350M 350M 381M 383M 383M 383M 383M
totalStockholdersEquity -4M -4M 3M 2M -48M -46M -12M
totalEquity -4M -4M 3M 2M -48M -46M -12M
totalLiabilitiesAndStockholdersEquity 18M 18M 35M 59M 159M 157M 168M
minorityInterest 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 18M 18M 35M 59M 159M 157M 168M
totalInvestments 0 0 18 000 15 000 15 000 15 000 15 000
totalDebt 214 000 214 000 2M 7M 123M 121M 94M
netDebt -3M -3M -5M -11M 103M 106M 67M
link Link Link Link Link
finalLink Link Link Link Link

Cash Flow Statement

Property 2025 q2 2025 q1 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2025-06-30 2025-03-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol RDHL RDHL RDHL RDHL RDHL RDHL RDHL
reportedCurrency USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-05 2025-04-10 2023-08-17 2023-08-17 2022-12-31 2022-09-30 2022-06-30
acceptedDate 2025-09-05 07:06:42 2025-04-10 07:51:10 2023-08-17 07:07:20 2023-08-17 07:07:20 2022-12-31 00:00:00 2022-09-29 20:00:00 2022-06-29 20:00:00
calendarYear 2025 2025 2023 2023 2022 2022 2022
period Q2 Q1 Q2 Q1 Q4 Q3 Q2
netIncome -2M -2M 761 000 50M -4M -36M -12M
depreciationAndAmortization 84 000 84 000 -59M 60M 2M 2M 2M
deferredIncomeTax 0 0 0 0 0 0 0
stockBasedCompensation 148 500 148 500 705 000 144 000 1M 2M 618 000
changeInWorkingCapital -144 500 -144 500 638 000 3M 4M 342 000 -5M
accountsReceivables -1M -1M 4M 28M 1M -2M -8M
inventory 241 000 241 000 -3M 5M 2M -865 000 3M
accountsPayables 0 0 -1M 136 000 -554 000 411 000 -1M
otherWorkingCapital 1M 1M 1M -30M 2M 3M 1M
otherNonCashItems -529 000 -529 000 46M -121M -6M 26M -2M
netCashProvidedByOperatingActivities -3M -3M -11M -7M -2M -6M -17M
investmentsInPropertyPlantAndEquipment -2000 -2000 -7000 0 0 -22 000 -163 000
acquisitionsNet 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 -9M 0 0
otherInvestingActivites 0 0 0 0 0 0 0
netCashUsedForInvestingActivites -2000 -2000 -7000 0 -9M -22 000 -163 000
debtRepayment 0 0 -293 000 -296 000 -384 000 -621 000 -355 000
commonStockIssued 0 0 -2M 7M 8M 0 16M
commonStockRepurchased 0 0 -2M 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites 2M 2M 2M -2M 0 -5M -236 000
netCashUsedProvidedByFinancingActivities 2M 2M 3000 5M 7M -6M 15M
effectOfForexChangesOnCash 4500 4500 18 000 -21 000 -16 000 -13 000 -32 000
netChangeInCash 0 0 -11M -2M 5M -12M -2M
cashAtEndOfPeriod 0 0 7M 18M 20M 15M 27M
cashAtBeginningOfPeriod 0 0 18M 20M 15M 27M 29M
operatingCashFlow -3M -3M -11M -7M -2M -6M -17M
capitalExpenditure -2000 -2000 -7000 0 0 -22 000 -163 000
freeCashFlow -3M -3M -11M -7M -2M -6M -17M
link Link Link Link Link
finalLink Link Link Link Link

Earning call transcript

2022 q1
2022-06-23 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 6
2025-12-31 16:58 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-31 16:58 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-23 07:00 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-23 07:00 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-23 07:00 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-15 07:03 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-12-01 07:02 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-11-26 21:02 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-11-26 21:02 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-11-26 21:02 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-11-04 14:33 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-22 20:55 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-21 11:00 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-21 11:00 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-20 13:04 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-20 13:04 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-10-06 12:04 ET
RedHill Biopharma published news for 2025 q3
SEC form 6
2025-09-29 11:04 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 13:31 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 13:31 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 13:31 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 13:31 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 11:06 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 11:06 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-09-05 11:06 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-08-20 13:01 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-08-18 13:03 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-08-14 11:00 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-07-21 13:02 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-07-01 16:02 ET
RedHill Biopharma published news for 2025 q2
SEC form 6
2025-06-25 21:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-06-25 21:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-06-25 21:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-06-25 21:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-27 11:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-19 20:05 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-19 20:05 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-13 07:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-05 12:04 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-05-02 11:01 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-28 11:05 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-17 20:06 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-16 11:02 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-10 11:51 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 20
2025-04-10 00:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-08 11:00 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-04-01 20:05 ET
RedHill Biopharma published news for 2025 q1
SEC form 6
2025-03-26 07:00 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-03-18 11:02 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-03-12 11:01 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-27 12:01 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-25 12:04 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-04 12:04 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-03 21:28 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-03 21:28 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-03 21:28 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2025-02-03 21:28 ET
RedHill Biopharma published news for 2024 q4
SEC form 6
2024-12-10 07:03 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-12-02 07:03 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-10-28 07:01 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-10-22 07:01 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-10-15 06:02 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-10-01 07:02 ET
RedHill Biopharma published news for 2024 q3
SEC form 6
2024-08-29 07:07 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-29 07:07 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-29 07:07 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-26 07:02 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-21 07:04 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-19 07:01 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-16 07:13 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-13 08:35 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-06 07:00 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-08-01 07:05 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-07-22 07:04 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-07-09 08:03 ET
RedHill Biopharma published news for 2024 q2
SEC form 6
2024-06-06 09:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-06-03 07:04 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-05-06 07:01 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-24 07:05 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-08 09:28 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 20
2024-04-08 09:25 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-04 16:05 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-03 07:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-03 07:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-03 07:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-03 07:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-03 07:00 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-04-02 07:02 ET
RedHill Biopharma published news for 2024 q1
SEC form 6
2024-03-21 16:05 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-03-20 16:38 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-03-14 16:03 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-03-11 07:01 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-03-05 07:01 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-02-20 16:05 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-02-20 07:01 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-02-13 16:05 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 12:50 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-26 09:31 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-25 09:09 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2024-01-25 06:02 ET
RedHill Biopharma published news for 2023 q4
SEC form 6
2023-12-20 08:45 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-12-12 07:03 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-12-06 07:01 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-12-04 07:03 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-12-01 16:10 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-11-27 07:01 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-11-16 12:00 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-11-14 08:02 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-10-16 16:05 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-10-10 09:08 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-10-03 07:03 ET
RedHill Biopharma published news for 2023 q3
SEC form 6
2023-09-29 08:02 ET
RedHill Biopharma published news for 2023 q2
SEC form 6
2023-09-22 16:17 ET
RedHill Biopharma published news for 2023 q2
SEC form 6
2023-08-17 00:00 ET
RedHill Biopharma published news for 2023 q2
SEC form 6
2023-07-06 07:00 ET
RedHill Biopharma published news for 2023 q2
SEC form 6
2023-06-29 07:00 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-06-12 08:01 ET
RedHill Biopharma reported for 2023 q1
SEC form 6
2023-05-22 07:02 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-05-15 18:21 ET
RedHill Biopharma published news for 2023 q1
SEC form 20
2023-04-28 00:00 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-04-11 07:04 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-04-03 13:30 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-04-03 08:51 ET
RedHill Biopharma published news for 2023 q1
SEC form 6
2023-03-30 08:05 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-28 16:48 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-21 07:01 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-16 18:16 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-13 06:01 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-08 19:11 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-03-06 07:09 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-02-28 07:02 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-02-16 08:01 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-02-15 07:02 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-02-06 07:02 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-01-26 07:02 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-01-25 09:15 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-01-24 09:00 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2023-01-03 07:02 ET
RedHill Biopharma published news for 2022 q4
SEC form 6
2022-12-27 07:00 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-20 07:00 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-12 07:00 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-06 13:38 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-05 16:24 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-05 07:03 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-02 09:00 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-12-01 16:01 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-29 08:05 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-17 08:32 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-14 07:08 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-14 06:06 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-10 16:23 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-07 09:34 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-07 00:00 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-11-04 07:02 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-10-26 07:02 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-10-19 07:04 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-10-18 07:05 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-10-14 16:30 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-10-03 07:05 ET
RedHill Biopharma published news for 2022 q3
SEC form 6
2022-09-23 09:00 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-09-16 07:04 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-09-13 07:00 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-08-26 07:00 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-08-17 08:08 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-07-12 08:03 ET
RedHill Biopharma published news for 2022 q2
SEC form 6
2022-06-23 07:07 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-06-22 08:00 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-06-01 08:00 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-05-25 09:17 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-05-13 09:00 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-05-12 09:18 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-05-11 08:56 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-05-09 08:35 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-04-11 09:03 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-04-05 08:00 ET
RedHill Biopharma published news for 2022 q1
SEC form 6
2022-03-30 07:38 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-03-17 08:11 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-03-17 08:04 ET
RedHill Biopharma published news for 2021 q4
SEC form 20
2022-03-17 00:00 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-03-15 09:02 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-03-08 09:03 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-03-01 09:03 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-02-17 09:32 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-02-07 10:17 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-01-13 10:38 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2022-01-06 09:18 ET
RedHill Biopharma published news for 2021 q4
SEC form 6
2021-12-15 09:17 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-12-09 07:01 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-12-06 07:04 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-12-02 07:01 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-12-01 07:50 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-12-01 07:37 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-30 07:01 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-24 07:02 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-22 16:54 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-19 09:19 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-18 16:10 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-17 07:00 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-15 07:02 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-09 07:06 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-11-08 07:02 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-25 07:03 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-20 07:02 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-18 07:18 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-12 07:05 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-12 07:00 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-06 07:02 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-10-04 08:04 ET
RedHill Biopharma published news for 2021 q3
SEC form 6
2021-09-23 07:02 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-09-14 08:18 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-09-13 07:03 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-09-07 07:04 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-09-07 06:00 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-09-02 10:03 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-08-26 06:04 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-08-26 00:00 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-08-23 07:02 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-08-19 07:03 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-07-26 09:00 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-07-22 09:25 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-07-20 07:02 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-07-19 07:06 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-07-13 11:05 ET
RedHill Biopharma published news for 2021 q2
SEC form 6
2021-06-28 07:01 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-06-21 07:03 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-06-17 09:11 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-06-10 08:00 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-06-09 07:01 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-06-07 07:05 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-27 07:00 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-26 16:02 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-26 07:00 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-24 07:00 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-21 12:28 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-05-20 07:00 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-04-09 07:04 ET
RedHill Biopharma published news for 2021 q1
SEC form 6
2021-03-25 09:27 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-22 07:03 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-18 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-18 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-11 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-05 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-03-04 09:19 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-02-23 07:10 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-02-18 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-02-17 07:09 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-02-09 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-02-02 08:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-29 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-28 07:31 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-14 14:28 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-14 09:21 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-11 16:45 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-11 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2021-01-06 07:00 ET
RedHill Biopharma published news for 2020 q4
SEC form 6
2020-12-31 09:30 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-12-22 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-12-15 09:30 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-12-14 08:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-12-07 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-25 10:42 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-23 08:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-20 08:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-19 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-17 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-16 10:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-13 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-12 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-05 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-11-04 10:30 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-26 10:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-26 09:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-14 11:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-13 10:30 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-08 10:30 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-07 10:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-10-06 07:00 ET
RedHill Biopharma published news for 2020 q3
SEC form 6
2020-09-22 07:14 ET
RedHill Biopharma published news for 2020 q2